Active clinical research studies
Dr. Barbara Jahnke and the Clinical Research Department at FNI are now screening patients with relapsing remitting multiple sclerosis. The TOWER study is evaluating the use of an oral medication called Teriflunomide. To see if you might qualify to participate please click on this link http://tower3.msstudies.com/

Doctor David Wiersema and Daniel Duffy along with the Clinical Research Department at FNI are now screening patients with foot drop as a result of a stroke for possible participation in the InStride study. This research study is evaluating the use of the WalkAide device. Potential participants must be on Medicare or be Medicare eligible. For more information on the InStride study please call 989-497-3023 or 989-497-3046. For more information on the WalkAide device please go to www.Walkaide.com